The duration of ERK pathway signalling determines the proliferative response of cells. A recent study has shown that cell cycle re-entry requires the downregulation of an anti-proliferative gene cluster following sustained activation of the ERK pathway.
It is becoming increasingly clear that cellular signalling pathways are not simple 'on-off' switches but that spatial and temporal effects are important in determining the outcomes and biological effects of these pathways. This is exemplified by the ERK MAP kinase pathway where differential biological outcomes can be elicited depending on the duration of activation of the pathway (reviewed in [1, 2] ). Indeed, the ERK MAP kinase cascade plays an important role in controlling cellular proliferation and differentiation, and in certain cell types, such as neuronally derived PC12 cells, the decision between these two endpoints is dependent on sustained signalling (reviewed in [1, 3] ). In fibroblasts, the induction of cell cycle re-entry requires sustained ERK signalling and the subsequent activation of successive waves of gene expression, culminating in a set of proliferative genes that includes cyclin D1 [2, [4] [5] [6] . This gene activation process was considered to be sufficient to send quiescent cells back into the cell cycle. However, a recent study from Nishida and colleagues [7] , published recently in Current Biology, has focused on the response of fibroblasts to sustained ERK signalling and has revealed a novel molecular mechanism underlying this phenomenon. In addition to the activation of gene expression, the repression of a cohort of antiproliferative genes was found to be a key determinant of how sustained ERK signalling can permit a proliferative response to growth factor signalling [7] .
In fibroblasts, different growth factors generate different profiles of ERK pathway activation. While FGF causes sustained ERK pathway activation and promotes proliferation, EGF is incapable of generating sustained ERK pathway activation and a proliferative response in this cell type. The progression of fibroblasts from a quiescent to proliferative state is characterised by the induction of interdependent waves of gene expression. The first of these involves immediate early genes, which are then directly responsible for triggering the expression of the delayed early genes [8] [9] [10] . One of these delayed early genes encodes cyclin D1, which plays a pivotal role in enabling cells to re-enter the cell cycle and progress into S phase. Importantly, cyclin D1 expression is not activated by transient ERK signalling but is only triggered after sustained activation of this pathway [11] [12] [13] . AP-1 family proteins play a major part in cyclin D1 regulation at the transcriptional level and one of these proteins, c-Fos, is encoded by a key immediate early gene activated by the ERK pathway. However, while both transient and sustained ERK pathway signalling upregulate c-fos transcription, only sustained ERK signalling leads to hyperphosphorylation of c-Fos protein and its subsequent stabilisation ( Figure 1) [2, 14, 15] . This stabilisation then allows it to activate the expression of the delayed early genes, culminating in cyclin D1 activation and S phase entry. Thus, c-Fos can act as a molecular sensor for the levels of ERK pathway activation that can ultimately promote entry into S phase. The recent work from Nishida and colleagues [7] has now identified another important molecular event that is at least in part directly controlled by c-Fos and other AP-1 components in response to sustained ERK signalling -the downregulation of a key group of anti-proliferative genes.
To address the mechanisms responsible for the differential proliferative response to the duration of ERK pathway signalling, Nishida and colleagues turned to NIH3T3 fibroblasts [7] . In this model system, FGF gives an initial transient burst of ERK pathway activation followed by sustained activation and a proliferative response, whereas other growth factors, such as PDGF and EGF, only induce transient activation of this pathway and are non-mitogenic. Using microarray analysis, a cluster of genes were identified which are downregulated in response to FGF signalling in an ERK-dependent manner. This cohort of genes was only downregulated under conditions of sustained ERK signalling. A number of these genes encode transcription factors, such as JunD, Sox6 and MEF2C, suggesting that these transcriptional regulators may be important in determining downstream responses to sustained signalling. Indeed, many of these have previously been shown to be anti-proliferative and the authors demonstrate that overexpression of these factors reduces the proliferative capacity of fibroblasts. Other genes that were downregulated under these conditions also exhibit similar anti-proliferative properties. For example, RNAi-mediated depletion of Gadd45a, Cpeb4 and Tob1 increases the proliferative capacity of cells. Importantly, therefore, a cohort of genes has been identified that has anti-proliferative capacity and must be downregulated to permit cell cycle re-entry. As the expression of these genes is only affected following sustained MAP kinase signalling, these genes may act as a fail-safe mechanism to prevent accidental triggering of cell cycle re-entry by inappropriate signals that only generate a transient response.
What then is the link between immediate early gene products and the regulation of this group of anti-proliferative genes? While not extensive, clear links are established between a requirement for c-Fos/AP-1 activity and the downregulation of this cohort of genes. Dominant-negative c-Fos constructs interfere with the downregulation of the majority of anti-proliferative genes, demonstrating c-Fos's involvement in this event. Indeed, some of the genes such as JunD
and repression is unclear, but one possible mechanism through which it might act in an indirect manner would be through the upregulation of a transcriptional repressor protein ( Figure 1B) .
Together with previous studies, a more comprehensive model can now be proposed for how sustained MAP kinase signalling can lead to cell-cycle re-entry in fibroblasts (Figure 1 ), involving the triggering of secondary gene expression programmes (the delayed early genes) through both repressive and activating activities. Both of these activities are promoted by c-Fos which is itself the molecular sensor for detecting sustained ERK signalling activity. Importantly, this new model might shed light on some outstanding questions and have an impact on our ability to control cancer. In contrast to the situation in fibroblasts, transient ERK signalling in neuronally derived PC12 cells leads to proliferation, whereas sustained signalling leads to differentiation of these cells (reviewed in [1, 2] ). Thus, this clear difference from the situation in fibroblasts illustrates that there are cell-type-specific mechanisms that interpret the signalling status of the ERK pathway and translate it into a distinct cellular response. Why, therefore, is a proliferative response not elicited in PC12 cells following sustained ERK signalling but instead in response to transient signalling? This latter observation might be explained if the anti-proliferative gene cluster is maintained at a low level in PC12 cells compared with fibroblasts, negating the need to downregulate this cluster and permitting cell cycle re-entry in response to transient signalling. Sustained signalling could instead activate an alternative cohort of genes required for differentiation. Finally, another important implication of the study relates to cancer cells that often have high basal levels of ERK pathway activity, caused through either overexpression or oncogenic mutation of pathway components such as Ras or B-Raf (reviewed in [3] ). It would be interesting to determine the status of the anti-proliferative gene cluster identified by Nishida and colleagues [7] across a number of these cancers. Through selective re-activation of the anti-proliferative genes, it might be possible to block ERK-pathway-mediated oncogenic events and hence provide an effective therapeutic strategy. Thus, in addition to between their system -hybrids of the two mustard species Arabidopsis thaliana and A. arenosa (Figure 1 ) -and hybrids in other plants, mice, treefrogs and Drosophila. From an evolutionary perspective, the A. thaliana x A. arenosa hybrids are also interesting because hybridization between these species has successfully occurred in the wild at least once, giving rise to a new allopolyploid species, A. suecica [2] (Figure 1B) .
Crosses between parents that have a different number of chromosome sets, known as interploidy crosses, have relatively low success rates. In plants, interploidy crosses generally fail during development of the endosperm, a maternal extraembryonic tissue essential for seed development [3] . Endosperm development is very sensitive to parental genome dosage. This has been proposed to result from a requirement for balanced expression levels of a limited number of imprinted genesgenes expressed only from either the maternal or paternal allelerather than the entire genome [4] . Consistent with this, proper endosperm development depends critically on several genes known to be imprinted. Disruption of these genes results in endosperm defects similar to those observed in interploidy crosses, suggesting a causal relationship [5, 6] .
Major genome-wide changes in gene silencing and DNA methylation patterns often occur in interploidy crosses in plants [7] . Nevertheless, in at least some cases, aberrations observed in interploidy crosses seem to be attributable to genic interactions. Josefsson et al. [1] found that misregulation of an imprinted gene PHERES1 (PHE1) is specific to the hybrid context, and not caused by ploidy differences per se. PHE1 over-expression was observed in A. thaliana x A. arenosa hybrid seeds, but not in A. thaliana interploidy crosses [1] . This parallels another recent study [8] ,
